Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:boardMemberOf |
gptkb:Foundation_Medicine
gptkb:Tempus gptkb:Adaptive_Biotechnologies gptkb:PetDx gptkb:TMRW_Life_Sciences gptkb:TScan_Therapeutics |
| gptkbp:education |
gptkb:Boston_College
gptkb:Wharton_School_of_the_University_of_Pennsylvania gptkb:Jefferson_Medical_College |
| gptkbp:employer |
Section 32
|
| gptkbp:field |
gptkb:biotechnology
healthcare |
| gptkbp:formerPosition |
CEO of Foundation Medicine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Michael J. Pellini
|
| gptkbp:knownFor |
former CEO of Foundation Medicine
|
| gptkbp:nationality |
gptkb:American
|
| gptkbp:occupation |
gptkb:business_executive
gptkb:physician |
| gptkbp:position |
Managing Partner at Section 32
|
| gptkbp:bfsParent |
gptkb:Foundation_Medicine
|
| gptkbp:bfsLayer |
6
|